Biotech · Private company
Zynerba Pharmaceuticals, Inc.
Track this companyFree. Adds Zynerba Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ZYN002 - Cannabidiol Transdermal GelPhase 3 · Fragile X SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)PHASE2 · COMPLETED · started Feb 19, 2020ClinicalTrials.gov NCT05149898 · fetched Nov 12, 2026
- Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXSPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 9, 2018ClinicalTrials.gov NCT03802799 · fetched Nov 12, 2026
- Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)PHASE2_PHASE3 · COMPLETED · started Jun 12, 2018ClinicalTrials.gov NCT03614663 · fetched Nov 12, 2026